| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V78042 | Anti-Mouse CD19 Antibody (1D3) | Anti-Mouse CD19 Antibody (1D3) is an anti-mouse CD19 IgG2a antibody inhibitor. | |
|
V86811 | Budoprutug | Budoprutug is a human IgG1 kappa monoclonal antibody against CD19. | |
|
V78686 | CD19 CAR circRNA | CD19 CAR circRNA can express CD19 car protein and can be used for chimeric antigen receptor T cell immunotherapy (CAR-CD19). | |
|
V78687 | CD19 car circRNA-LNP | CD19 car circRNA-LNP is a lipid nanoparticle (LNP) containing CD19 car circRNA, which is suitable for detection of RNA delivery, translation efficiency, cell viability, etc. | |
|
V86814 | CD19 CAR mRNA (Human) | CD19 CAR mRNA (Human) can express human CD19 CAR protein and can be used for chimeric antigen receptor T cell immunotherapy (CAR-CD19). | |
|
V86813 | CD19 car mRNA (Mouse)-LNP | CD19 car mRNA (Mouse)-LNP is a lipid nanoparticle (LNP) containing CD19 car mRNA, which is suitable for RNA delivery, translation efficiency, cell viability and other detection. | |
|
V78689 | CD19 car mRNA-LNP | CD19 car mRNA-LNP is a lipid nanoparticle (LNP) containing CD19 car mRNA, suitable for detection of RNA delivery, translation efficiency, cell viability, etc. | |
|
V78688 | CD19 CARmRNA | CD19 CAR mRNA can express CD19 car protein and can be used for chimeric antigen receptor T cell immunotherapy (CAR-CD19). | |
|
V132036 | Coltuximab | Coltuximab is a humanized antibody expressed in CHO cells that targets CD19. | |
|
V133697 | DI-B4 | DI-B4 is an anti-CD19 monoclonal antibody that can bind to CD19 on the surface of B cells and has anti-tumor activity. | |
|
V79307 | Englumafusp alfa (CD19-4-1BBL; RO7227166; RG6076) | Englumafusp alfa (CD19-4-1BBL; RO7227166) is a fusion construct consisting of a CD19-specific antibody domain fused to the trimerizing ectodomain of human 41BBL. | |
|
V136544 | GBR-401 | 1931954-95-8 | GBR-401 is a humanized anti-CD19 monoclonal antibody with high affinity for FcγRIIIa. |
|
V137747 | IASO-782 | IASO-782 is a fully human monoclonal antibody that targets human CD19. | |
|
V137945 | Inebilizumab (FUT8-KO) | Inebilizumab (FUT8-KO) is an anti-CD19 monoclonal antibody expressed by CHO cells with the fucosyltransferase 8 gene (FUT8) knocked out. | |
|
V139161 | LY3541860 | LY3541860 is a selective anti-CD19 antibody that binds to human CD19 with high affinity and selectively binds to human B cells (human Kd value 76.8 pM, cynomolgus monkey Kd value 94.5 nM). | |
|
V74758 | MDX-1342 | 1646327-65-2 | MDX-1342 is a fully human monoclonal antibody (mAb) (HuMAb) targeting the CD19 membrane receptor. |
|
V74759 | Tisagenlecleucel (CTL019) | 1823078-37-0 | Tisagenlecleucel (CTL019) is an autologous anti-CD19 chimeric antigen receptor (CAR) T cell therapy. |
|
V86812 | Zeripatamig | Zeripatamig is a human IgG1 kappa monoclonal antibody against CD19/CD47. |